Skip to main content

Advertisement

SpringerLink
Log in

HLA-B*5701 and HLA-B*5801 in an Indian patient with anti-epileptics induced cutaneous adverse drug reactions

  • Letter to the Editor
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC (2001) Acute generalized exanthematous pustulosis (AGEP)--a clinical reaction pattern. J Cutan Pathol 28:113–119

    Article  CAS  PubMed  Google Scholar 

  2. Chen P, Lin J-J, Lu C-S, Ong C-T, Hsieh PF, Yang C-C et al (2011) Carbamazepine-induced toxic effects and HLA-B* 1502 screening in Taiwan. N Engl J Med 364:1126–1133. https://doi.org/10.1056/NEJMoa1009717

    Article  CAS  PubMed  Google Scholar 

  3. Kaniwa N, Saito Y, Aihara M, Matsunaga K, Tohkin M, Kurose K, Furuya H, Takahashi Y, Muramatsu M, Kinoshita S, Abe M, Ikeda H, Kashiwagi M, Song Y, Ueta M, Sotozono C, Ikezawa Z, Hasegawa R, for the JSAR research group (2010) HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients. Epilepsia 51:2461–2465. https://doi.org/10.1111/j.1528-1167.2010.02766.x

    Article  CAS  PubMed  Google Scholar 

  4. Ikeda H, Takahashi Y, Yamazaki E, Fujiwara T, Kaniwa N, Saito Y, Aihara M, Kashiwagi M, Muramatsu M (2010) HLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions. Epilepsia 51:297–300. https://doi.org/10.1111/j.1528-1167.2009.02269.x

    Article  PubMed  Google Scholar 

  5. Song JS, Kang E-S, Joo EY, Hong SB, Seo D-W, Lee S-Y (2014) Absence of HLA-B*1502 and HLA-A*3101 alleles in 9 Korean patients with antiepileptic drug-induced skin rash: a preliminary study. Ann Lab Med 34:372–375. https://doi.org/10.3343/alm.2014.34.5.372

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Amstutz U, Ross CJD, Castro-Pastrana LI, Rieder MJ, Shear NH, Hayden MR, Carleton BC, CPNDS Consortium (2013) HLA-A*31:01 and HLA-B*15:02 as genetic markers for carbamazepine hypersensitivity in children. Clin Pharmacol Ther 94:142–149. https://doi.org/10.1038/clpt.2013.55

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Hung S-I, Chung W-H, Liu Z-S, Chen C-H, Hsih M-S, Hui RC, Chu CY, Chen YT (2010) Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese. Pharmacogenomics 11:349–356. https://doi.org/10.2217/pgs.09.162

    Article  CAS  PubMed  Google Scholar 

  8. Mallal S, Phillips E, Carosi G, Molina J-M, Workman C, Tomazic J, Jägel-Guedes E, Rugina S, Kozyrev O, Cid JF, Hay P, Nolan D, Hughes S, Hughes A, Ryan S, Fitch N, Thorborn D, Benbow A, PREDICT-1 Study Team (2008) HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 358:568–579. https://doi.org/10.1056/NEJMoa0706135

    Article  PubMed  Google Scholar 

  9. Kannabiran C, Ueta M, Sangwan V, Rathi V, Basu S, Tokunaga K, Kinoshita S (2017) Association of human leukocyte antigen class 1 genes with Stevens Johnson syndrome with severe ocular complications in an Indian population. Sci Rep 7(15960):15960. https://doi.org/10.1038/s41598-017-15965-7

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Ozeki T, Mushiroda T, Yowang A, Takahashi A, Kubo M, Shirakata Y, Ikezawa Z, Iijima M, Shiohara T, Hashimoto K, Kamatani N, Nakamura Y (2011) Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population. Hum Mol Genet 20:1034–1041. https://doi.org/10.1093/hmg/ddq537

    Article  CAS  PubMed  Google Scholar 

  11. Chung W-H, Chang W-C, Lee Y-S, Wu Y-Y, Yang C-H, Ho H-C, Chen MJ, Lin JY, Hui RC, Ho JC, Wu WM, Chen TJ, Wu T, Wu YR, Hsih MS, Tu PH, Chang CN, Hsu CN, Wu TL, Choon SE, Hsu CK, Chen DY, Liu CS, Lin CY, Kaniwa N, Saito Y, Takahashi Y, Nakamura R, Azukizawa H, Shi Y, Wang TH, Chuang SS, Tsai SF, Chang CJ, Chang YS, Hung SI, Taiwan Severe Cutaneous Adverse Reaction Consortium, Japan Pharmacogenomics Data Science Consortium (2014) Genetic variants associated with phenytoin-related severe cutaneous adverse reactions. JAMA 312:525–534. https://doi.org/10.1001/jama.2014.7859

    Article  PubMed  Google Scholar 

  12. Genin E, Chen D-P, Hung S-I, Sekula P, Schumacher M, Chang P-Y, Tsai SH, Wu TL, Bellón T, Tamouza R, Fortier C, Toubert A, Charron D, Hovnanian A, Wolkenstein P, Chung WH, Mockenhaupt M, Roujeau JC (2014) HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis. Pharmacogenomics J 14(3):281–288. https://doi.org/10.1038/tpj.2013.40

    Article  CAS  PubMed  Google Scholar 

  13. Li-Wan-Po A, Girard T, Farndon P, Farndon P, Cooley C, Lithgow J (2010) Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17. Br J Clin Pharmacol 69:222–230. https://doi.org/10.1111/j.1365-2125.2009.03578.x

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Patil KM, Bodhankar SL (2005) Simultaneous determination of lamotrigine, phenobarbitone, carbamazepine and phenytoin in human serum by high-performance liquid chromatography. J Pharm Biomed Anal 39:181–186. https://doi.org/10.1016/j.jpba.2005.02.045

    Article  CAS  PubMed  Google Scholar 

  15. Hayes G, Kootsikas ME (1993) Reassessing the lower end of the phenytoin therapeutic range: a review of the literature. Ann Pharmacother 27:1389–1392. https://doi.org/10.1177/106002809302701114

    Article  CAS  PubMed  Google Scholar 

  16. Winnicka RI, Topaciński B, Szymczak WM, Szymańska B (2002) Carbamazepine poisoning: elimination kinetics and quantitative relationship with carbamazepine 10,11-epoxide. J Toxicol Clin Toxicol 40:759–765

    Article  CAS  PubMed  Google Scholar 

  17. Klein K, Zanger UM (2013) Pharmacogenomics of cytochrome P450 3A4: recent progress toward the “missing heritability” problem. Front Genet 4:12. https://doi.org/10.3389/fgene.2013.00012

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Funding

The study was supported by intramural funds from the Central Inter-disciplinary Research Facility (CIDRF), Sri Balaji Vidyapeeth (SBV) (Deemed-to-be University), Puducherry, India.

Author information

Authors and Affiliations

  1. Central Inter-Disciplinary Research Facility, Sri Balaji Vidyapeeth (Deemed-to-be University), Puducherry, India

    Aarthi Manoharan

  2. Department of General Medicine, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth (Deemed-to-be University), Puducherry, India

    Ajay Sam Kumar & Bhargav Kiran Gaddam

  3. Department of Dermatology, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth (Deemed-to-be University), Puducherry, India

    Ambujam Sreedevi

  4. Jeevan Stem Cell Foundation, Chennai, India

    Aruna Devi Sathishkannan

Authors
  1. Aarthi Manoharan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ajay Sam Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ambujam Sreedevi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Aruna Devi Sathishkannan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bhargav Kiran Gaddam
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Aarthi Manoharan designed the study, performed the research, analyzed the data, and prepared the manuscript. Ajay Sam Kumar, Ambujam Sreedevi, and Bhargav Kiran Gaddam conceived the study and the study design. Aruna Devi Sathishkannan performed the research and data analysis.

Corresponding author

Correspondence to Ajay Sam Kumar.

Ethics declarations

All procedures performed in the study involving human participant were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from the participant involved in the study.

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Manoharan, A., Kumar, A.S., Sreedevi, A. et al. HLA-B*5701 and HLA-B*5801 in an Indian patient with anti-epileptics induced cutaneous adverse drug reactions. Eur J Clin Pharmacol 75, 599–601 (2019). https://doi.org/10.1007/s00228-018-02618-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-018-02618-5

Search

Navigation